Cargando…

Lipoprotein(a) in nephrological patients

In contrast to existing EAS/ESC guidelines on the management of lipid disorders, current recommendations from nephrological societies are very conservative and restrictive with respect to any escalation of lipid lowering/statin therapy. Furthermore, lipoprotein(a) (Lp(a)) – an established cardiovasc...

Descripción completa

Detalles Bibliográficos
Autor principal: Hohenstein, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352768/
https://www.ncbi.nlm.nih.gov/pubmed/28181057
http://dx.doi.org/10.1007/s11789-017-0086-z